Effects of daily consumption of probiotic yoghurt on inflammatory factors in pregnant women: A randomized controlled trial

Pakistan Journal of Biological Sciences

Volumn 14, Issue 8, 2011, Pages 476-482

  Asemi, Zatollah ^a   Jazayeri, Shima ^a   Najafi, Mohammad ^a   Samimi, Mansoreh ^b   Mofid, Vahid ^a   Shidfar, Farzad ^a   Foroushani, Abbas Rahim ^a   Shahaboddin, Mohamad Esmaiel ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

hs CRP; Inflammatory factors; Pregnant women; Probiotic yoghurt; TNF

Indexed keywords

BIFIDOBACTERIUM; LACTOBACILLUS ACIDOPHILUS;

EID: 80051519834     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2011.476.482     Document Type: Article

References (51)

1. Abdin, A.A. and E.M. Saeid, 2008. An experimental study on ulcerative colitis as a potential target for probiotic therapy by Lactobacillus acidophilus with or without olsalazine. J. Crohn's Colitis, 2: 296-303.
2. Anderson, A.D.G., CE. McNaught, P.K. Jain and J. MacFie, 2004. Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut, 53: 241-245.
3. Araki, Y., A. Andoh, J. Takizawa, W. Takizawa and Y. Fujiyama, 2004. Clostridium butyricum, a probiotic derivative, suppresses dextran sulfate sodium-induced experimental colitis in rats. Int. J. Mol. Med., 13: 577-580.
4. Boutsikou, T., G. Mastorakos, M. Kyriakakou, A. Margeli, D. Hassiakos et al, 2010. Circulating levels of inflammatory markers in intrauterine growth restriction. Mediators Inflamm., 2010: 1-7.
5. Ciancili, F., C. Cortesini, O. Fantappie, L. Messerini and I. Sardi et al., 2004. Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer. Clin. Cancer Res., 10: 2694-2704.
6. Dasanayake, A.P., 1998. Poor periodontal health of the pregnant woman as a risk factor for low birth weight. Ann. Periodontol., 3: 206-212.
7. Del Águila, L.F., K.P. Claffey and J.P. Kirwan, 1999. TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells. Am. J. Physiol., 276: E849-E855.
8. Fleige, S., W. Precinger, H.H.D. Meyer and M.W. Pfaffl, 2009. The immunomodulatory effect of lactulose on Enterococcus faecium fed preruminant calves. J. Anim. Sci., 87: 1731-1738.
9. Furrie, E., S. Macfarlane, A. Kennedy, J.H. Cummings, S.V Walsh, D.A O'Neil and G.T. Macfarlane, 2005. Synbiotic therapy (Bifidobacterium longumlSynergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: A randomised controlled pilot trial. Gut, 54: 242-249.
10. Guitard, J., J. Menotti, A. Desveaux, P. Alimardani, R. Porcher, F. Derouin and N.Kapel, 2006. Experimental study of the effects of probiotics on Cryptosporidium parvum infection in neonatal rats. Parasitol. Res., 99: 522-527.
11. Gupta, P., M. Narang, B.D. Banerjee and S. Basu, 2004. Oxidative stress in term small for gestational age neonates born to undernourished mothers: A case control study. BMC pediatrics, 4: 14-14.
12. Hatakka, K., J. Martio, M. Korpela, M. Herranen and T. Poussa et al, 2003. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis: A pilot study. Scand. J. Rheumatol, 32: 211-215.
13. Hegazy, S.K. and M.M. El-Bedewy, 2010. Effect of probiotics on pro-inflammatory cytokines and NF-kB activation in ulcerative colitis. World J. Gastroenterol, 16: 4145-4151.
14. Jahromi, A.S., P. Zareian and A. Madani, 2011. Association of insulin resistance with serum Interleukin-6 and TNF-α levels during normal pregnancy. Biomark Insights, 6: 1-6.
15. Jeffcoat, M.K., N.C. Geurs, M.S. Reddy, S.P. Cliver, R.L. Goldenberg and J.C. Hauth, 2001. Periodontal infection and preterm birth: Results of a prospective study. J. Am. Dent. Assoc., 132: 875-880.
16. Kamiya, K., M. Wang, S. Uchida, S. Amano, T. Oshika, N. Sakuragawa and J. Hori, 2005. Topical application of culture supernatant from human amniotic epithelial cells suppresses inflammatory reactions in cornea. Exp. Eye Res., 80: 671-679.
17. Kirwan, TP., R.K. Krishnan, I.A. Weaver, T.F. Del Águila and W.J. Evans, 2001. Human aging is associated with altered TNF-α production during hyperglycemia and hyperinsulinemia. Am. J. Physiol. Endocrinol. Metab.,281:E1137-E1143.
18. Kirwan, TP., S. Hauguel-De Mouzon, J. Tepercq, J.C. Challier and T. Huston-Presley et al, 2002. TNF-α is a predictor of insulin resistance in human pregnancy. Diabetes, 51: 2207-2213.
19. Konishi, N., C. Miki, T. Yoshida, K. Tanaka, Y. Toiyama and M. Kusunoki, 2005. Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma. Oncology, 68: 138-145.
20. Tau, D.C.W., B. Dhillon, H. Yan, P.E. Szmitko and S. Venna, 2005. Adipokines: Molecular links between obesity and atheroslcerosis. Am. J. Physiol. Heart Circulatory Physiol, 288: H2031-H2041.
21. Tin, Y.P., CH. Thibodeaux, J.A. Pena, G.D. Ferry and J. Versalovic, 2008. Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflamm. Bowel. Dis., 14: 1068-1083.
22. Tiong, M.T. and N.P. Shah, 2006. Effects of a Lactobacillus casei synbiotic on serum lipoprotein, intestinal microflora and organic acids in rats. J. Dairy Sci., 89: 1390-1399.
23. Tiong, M.T., 2008. Roles of probiotics and prebiotics in colon cancer prevention: Postulated mechanisms and In-vivo evidence. Int. J. Mol. Sci., 9: 854-863.
24. Tm, J.B., T. Jia, B.R. Ti, T.Z. Tan, Q. Ge, H.T. Zhen and H.C. Deng, 2010. Adiponectin suppresses inflammatory responses at the early phase of atherosclerosis in hyperglycemic rats. Mol. Med. Report, 3: 323-328.
25. Mandel, D.R., K. Eichas and J. Holmes, 2010. Bacillus coagulans: A viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complement Altern. Med., 10: 1-1.
26. McNaught, CE., N.P. Woodcock, A.D.G. Anderson and J. MacFie, 2005. A prospective randomised trial of probiotics in critically ill patients. Clin. Nutr., 24: 211-219.
27. Melczer, Z., F. Banhidy, S. Csomor, M. Kovacs, P. Siklos, G. Winkler and K. Cseh, 2002. Role of tumour necrosis factor-α in insulin resistance during normal pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol, 105: 7-10.
28. Meyer, A.T., I. Elmadfa, I. Herbacek and M. Micksche, 2007. Probiotic, as well as conventional yogurt, can enhance the stimulated production of proinflammatory cytokines. J. Hum. Nutr. Diet, 20: 590-598.
29. Mistry, H.D., V. Wilson, M.M. Ramsay, M.E. Symonds and F.B. Pipkin, 2008. Reduced selenium concentrations and glutathione peroxidase activity in preeclamptic pregnancies. Hypertension, 52: 881-888.
30. Offenbacher, S., V. Katz, G. Fertik, J. Collins and D. Boyd et al, 1996. Periodontal infection as a possible risk factor for preterm low birth weight. J. Periodontal, 67: 1103-1113.
31. Ouchi, N, S. Kihara, T. Funahashi, T. Nakamura and M. Nishida, 2003. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation, 107: 671-674.
32. Pepys, M.B. and G.M. Hirschfield, 2003. C-reactive protein: A critical update. J. Clin. Invest, 111: 1805-1812.
33. Pipkin, F.B., 2001. Risk factors for preeclampsia. N. Engl. J. Med., 344: 925-926.
34. Pitiphat, W., M.W. Gillman, K.J. Joshipura, P.P. Williams, C.W. Douglass and J.W. Rich-Edwards, 2005. Plasma C-reactive protein in early pregnancy and preterm delivery. Am. J. Epidemiol, 162: 1108-1113.
35. Poston, T., A.T. Bnley, P.T. Seed, F.J. Kelly and A.H. Sherman, 2006. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): Randomised placebo-controlled trial. Tancet, 367: 1145-1154.
36. Rachmawati, H., L. Beljaars, C. Reker-Smit, H.I. Bakker, A.M. Van Loenen-Weemaes, M.N. Lub-De Hooge and K. Poelstra, 2011. Intravenous administration of recombinant human IL-10 suppresses the development of anti-thy 1-induced glomerulosclerosis in rats. PDA J. Pharm. Sci. Technol.,65: 116-130.
37. Ranganathan, N, E.A. Friedman, P. Tam, V. Rao, P. Ranganathan and R. Dheer, 2009. Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: A 6-month pilot scale trial in Canada. Curr. Med. Res. Opm, 25: 1919-1930.
38. Sadrzadeh-Yeganeh, H., I. Elmadfa, A. Djazayery, M. Jalali, R. Heshmat and M. Chamary, 2010. The effects of probiotic and conventional yoghurt on lipid profile in women. Br. J. Nutr., 103: 1778-1783.
39. Shimosato, T., T. Kimura, M. Tonno, I.D. Hiev and S. Katoh et al, 2006. Strong immunostimulatory activity of AT-oligodeoxynucleotide requires a six-base loop with a self-stabilized 5'-C. G-3' stem structure. Cell Microbiol., 8: 485-495.
40. Sibai, B., G. Dekker and M. Kupfermine, 2005. Pre-eclampsia. Lancet, 365: 785-799.
41. Srivastava, S.K., U.C. Yadav, A.B. Reddy, A. Saxena and R. Tammali et al, 2011. Aldose reductase inhibition suppresses oxidative stres s-induced inflammatory disorders. Chem. Biol. Interact., 191: 330-338.
42. Sugawara, G., M. Nagino, H. Nishio, T. Ebata and K. Takagi et al, 2006. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: A randomized controlled trial. Ann. Surg., 244: 706-714.
43. Szarka, A., J. Rigo Jr., L. Lazar, G. Beko and A. Molvarec, 2010. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol, 2: 11-59.
44. Timmerman, H., L. Niers, B. Ridwan, C. Koning and L. Mulder et al, 2007. Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clin. Nutr., 26: 450-459.
45. Tjoa, M.L, J.M.G. Van Vugt, A.T.J.J. GO, M.A. Blankenstein, C.B.M. Oudejans and I.J. Van Wijk, 2003. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J. Reprod. Immunol, 59: 29-37.
46. Vajro, P., C. Mandato, M.R. Licenziati, A. Franzese and D.F. Vitale et al, 2011. Effects oí Lactobacillus rhamnosus strain GG in pediatric Obesity-related liver disease. J. Pediatr. Gastroenterol. Nutr., 52: 740-743.
47. Van Minnen, L.P., H.T. Timmerman, F. Lutgendorff, A. Verheem and W. Harmsen et al, 2007. Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis. Surgery-St Louis, 141: 470-480.
48. Viljanen, M., E. Pohjavuori, T. Haahtela, R. Korpela and M. Kuitunen et al, 2005. Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome. J. Allergy Clin. Immunol, 115: 1254-1259.
49. Wan, Y.M., Y.Q. Zhu, B. Xia and J. Luo, 2010. Probiotic therapy using live combined bifidobacterium, lactobacillus and enterococcus for experimental colitis in rats model. Zhonghua Nei Ke Za Zhi, 49: 418-421.
50. Yadav, U.C., K.V. Ramana and S.K. Srivastava, 2011. Aldose reductase inhibition suppresses airway inflammation. Chem. Biol. Interact, 191: 339-345.
51. Zhang, J.W., P. Du, D.W. Chen, L. Cm and CM. Ymg, 2010. Effect of viable Bifidobacterium supplement on the immune status and inflammatory response in patients undergoing resection for colorectal cancer. Zhonghua Wei Chang Wai Ke Za Zhi, 13: 40-43.